Biomarker study in bariatric surgery patients with and without obstructive sleep apnea

Biomarker study in bariatric surgery patients with and without obstructive sleep apnea - Biomarker study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42714

Enrollment

135

Registered

2015-09-17

Start date

2015-09-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbide obesitas, bariatrische chirurgie, OSAS Obstructive sleep apnea

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients scheduled for primary laparoscopic roux-en-y gastric bypass (LRYGB) or primary laparoscopic sleeve gastrectomy (LSG)

Exclusion criteria

Exclusion criteria: Other bariatric surgical procedures than LRYGB or LSG, such as laparoscopich gastric banding or revisional surgery

Design outcomes

Primary

Measure	Time frame
1. Which biomarkers have a good agreement with PSG results, preoperatively? Could these biomarkers distinguish OSA/non-OSA patients, and no/mild/moderate/severe OSA patients?	—

Secondary

Measure	Time frame
2. What is the effect of bariatric surgery on these OSA associated biomarkers? 3. Are there biomarkers that predict the amelioration of OSA after bariatric surgery? 4. What is the relationship between OSA associated biomarkers, weight loss and other weight associated existing comorbidities including type II diabetes, hypertension and dyslipidemia? Including medication use.	—

Countries

Netherlands

Outcome results